Citation Impact
Citing Papers
Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer
2015
Combination Therapy of Bortezomib with Novel Targeted Agents: An Emerging Treatment Strategy
2010
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Carotenoids: biochemistry, pharmacology and treatment
2016 Standout
Regulatory T cells in autoimmune kidney diseases and transplantation
2023 StandoutNobel
Postoperative pain and quality of life after lobectomy via video-assisted thoracoscopic surgery or anterolateral thoracotomy for early stage lung cancer: a randomised controlled trial
2016 Standout
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Intracellular Delivery System for Antibody–Peptide Drug Conjugates
2015 StandoutNobel
Acetylation of Stat1 modulates NF-κB activity
2006
Synergistic induction of apoptosis and chemosensitization of human colorectal cancer cells by histone deacetylase inhibitor, scriptaid, and proteasome inhibitors: potential mechanisms of action
2012
EXPRESSION OF CONCERN: Antitumor effects of a novel sulfur‐containing hydroxamate histone deacetylase inhibitor H40
2008
Therapeutic potential of resveratrol: the in vivo evidence
2006 Standout
pVHL Acts as an Adaptor to Promote the Inhibitory Phosphorylation of the NF-κB Agonist Card9 by CK2
2007 StandoutNobel
Regulation of cell death and autophagy by IKK and NF‐κB: critical mechanisms in immune function and cancer
2012
Nuclear factor-κB inhibitors as sensitizers to anticancer drugs
2005
Review article: the role of butyrate on colonic function
2007 Standout
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
Spermidine/Spermine-N1-Acetyltransferase 2 Is an Essential Component of the Ubiquitin Ligase Complex That Regulates Hypoxia-inducible Factor 1α
2007 StandoutNobel
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Marine natural products
1990 Standout
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
Shared Principles in NF-κB Signaling
2008 Standout
Thoracoscopic Lobectomy versus Open Lobectomy in Stage I Non-Small Cell Lung Cancer: A Meta-Analysis
2013
NF-κB, the first quarter-century: remarkable progress and outstanding questions
2012 Standout
Principles of bioactive lipid signalling: lessons from sphingolipids
2008 Standout
Epigenetics and atherosclerosis
2009
Histone Deacetylase Inhibitors and Demethylating Agents: Clinical Development of Histone Deacetylase Inhibitors for Cancer Therapy
2007
Microenvironment Tumor Metabolic Interactions Highlighted by qMSI: Application to the Tryptophan-Kynurenine Pathway in Immuno-Oncology
2017
SMRT Derepression by the IκB Kinase α
2004
Engineering interferons and interleukins for cancer immunotherapy
2022
The complexity of NF-κB signaling in inflammation and cancer
2013 Standout
Anticancer activities of histone deacetylase inhibitors
2006 Standout
Delivery technologies for cancer immunotherapy
2019 Standout
Video-Assisted Thoracoscopic Surgery Versus Thoracotomy Lymph Node Dissection in Clinical Stage I Lung Cancer: A Meta-Analysis and System Review
2016
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Valproic Acid Inhibits Angiogenesis in Vitro and in Vivo
2004
Interplay between protein synthesis and degradation in the CNS: physiological and pathological implications
2006
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Treatment and Prognosis of Isolated Local Relapse after Stereotactic Body Radiotherapy for Clinical Stage I Non-Small-Cell Lung Cancer
2015
NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target
2010
Activation of notch‐1 enhances epithelial–mesenchymal transition in gefitinib‐acquired resistant lung cancer cells
2011
A case-matched study of anatomical segmentectomy versus lobectomy for stage I lung cancer in high-risk patients
2005
Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling
2012 Standout
TAT-Bim Induces Extensive Apoptosis in Cancer Cells
2007
Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection
2004
Basal and induced sphingosine kinase 1 activity in A549 carcinoma cells: function in cell survival and IL-1β and TNF-α induced production of inflammatory mediators
2005
Oxidative Stress in Cancer
2020 Standout
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
2012 Standout
Molecular mechanisms of necroptosis: an ordered cellular explosion
2010 Standout
Is video-assisted thoracic surgery lobectomy better than thoracotomy for early-stage non-small-cell lung cancer? A systematic review and meta-analysis
2013
HDAC inhibition prevents NF-κB activation by suppressing proteasome activity: Down-regulation of proteasome subunit expression stabilizes IκBα
2005
Self-projection and the brain
2006 Standout
Epigenetic modifications and human disease
2010 Standout
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
2006 Standout
Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
2004 Standout
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
2019 Standout
British Thoracic Society guidelines for the investigation and management of pulmonary nodules: accredited by NICE
2015
The NF- B Family of Transcription Factors and Its Regulation
2009 Standout
Spermidine/Spermine N1-Acetyltransferase 2 (SSAT2) functions as a coactivator for NF-κB and cooperates with CBP and P/CAF to enhance NF-κB-dependent transcription
2006
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Allogeneic tumor cell vaccines
2013
Sulfur(VI) Fluoride Exchange (SuFEx): Another Good Reaction for Click Chemistry
2014 StandoutNobel
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
A Switch from Canonical to Noncanonical Wnt Signaling Mediates Drug Resistance in Colon Cancer Cells
2011
Integrating cell-signalling pathways with NF-κB and IKK function
2006 Standout
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Postoperative Pneumonia after Major Lung Resection
2006
NAD + /NADH and NADP + /NADPH in Cellular Functions and Cell Death: Regulation and Biological Consequences
2007 Standout
Superoxide Dismutases: Role in Redox Signaling, Vascular Function, and Diseases
2011 Standout
Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
2009 Standout
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth
2008 StandoutNobel
Stereotactic ablative radiotherapy: A potentially curable approach to early stage multiple primary lung cancer
2013
IκB Kinase α-Mediated Derepression of SMRT Potentiates Acetylation of RelA/p65 by p300
2005
Incorporating Bortezomib into the Treatment of Lung Cancer
2007
Regulation and Function of NF-κB Transcription Factors in the Immune System
2009 Standout
Synthesis of Sulfonamides and Evaluation of Their Histone Deacetylase (HDAC) Activity
2007
Role of the Tumor Suppressor PTEN in Antioxidant Responsive Element-mediated Transcription and Associated Histone Modifications
2009
Regulation Mechanisms and Signaling Pathways of Autophagy
2009 Standout
An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells
2007 Standout
Evaluation of the Antiproliferative Activity of Diterpene Isonitriles from the SpongePseudoaxinella flavain Apoptosis-Sensitive and Apoptosis-Resistant Cancer Cell Lines
2011
Proteasome Inhibition Alleviates SNARE-Dependent Neurodegeneration
2012 StandoutNobel
Resolvin D1 inhibits TGF-β1-induced epithelial mesenchymal transition of A549 lung cancer cells via lipoxin A4 receptor/formyl peptide receptor 2 and GPR32
2013
Mechanism of the Anticancer Effect of Lycopene (Tetraterpenoids)
2015
The cardenolide UNBS1450 is able to deactivate nuclear factor κB–mediated cytoprotective effects in human non–small cell lung cancer cells
2006
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
An IL-2 mutein engineered to promote expansion of regulatory T cells arrests ongoing autoimmunity in mice
2020
Blockade of Histone Deacetylase Inhibitor-Induced RelA/p65 Acetylation and NF-κB Activation Potentiates Apoptosis in Leukemia Cells through a Process Mediated by Oxidative Damage, XIAP Downregulation, and c-Jun N-Terminal Kinase 1 Activation
2005
CLINICAL DEVELOPMENT OF HISTONE DEACETYLASE INHIBITORS AS ANTICANCER AGENTS
2004
Works of Chadrick E. Denlinger being referenced
IL-2 and Beyond in Cancer Immunotherapy
2018
The use of gamma-irradiation and ultraviolet-irradiation in the preparation of human melanoma cells for use in autologous whole-cell vaccines
2008
Inhibition of phosphatidylinositol 3-kinase/Akt and histone deacetylase activity induces apoptosis in non–small cell lung cancer in vitro and in vivo
2005
Combined histone deacetylase and NF-κB inhibition sensitizes non-small cell lung cancer to cell death
2004
Pulmonary segmentectomy: results and complications
2003
Ineffectiveness of Histone Deacetylase Inhibitors to Induce Apoptosis Involves the Transcriptional Activation of NF-κB through the Akt Pathway
2003
Modulation of antiapoptotic cell signaling pathways in non-small cell lung cancer: the role of NF-κB
2004
A Decade of Advances in Treatment of Early-Stage Lung Cancer
2011
Stereotactic body radiation therapy versus surgical resection for stage I non–small cell lung cancer
2010
Suberoylanilide Hydroxamic Acid Induces Akt-mediated Phosphorylation of p300, Which Promotes Acetylation and Transcriptional Activation of RelA/p65
2006
Combined proteasome and histone deacetylase inhibition in non–small cell lung cancer
2004
Lymph Node Evaluation in Video-Assisted Thoracoscopic Lobectomy Versus Lobectomy by Thoracotomy
2010
Proteasome inhibition sensitizes non–small cell lung cancer to histone deacetylase inhibitor–induced apoptosis through the generation of reactive oxygen species
2004
On-Tissue Localization of Ceramides and Other Sphingolipids by MALDI Mass Spectrometry Imaging
2014
Epithelial to mesenchymal transition: The doorway to metastasis in human lung cancers
2010
Proteasome Inhibition Sensitizes Non–Small-Cell Lung Cancer to Gemcitabine-Induced Apoptosis
2004
Efficacy of histone deacetylase inhibitors in NSCLC is attenuated by NF-kB acetylation
2004